Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
They are a barrier to needed therapies with real human consequences
In the short term, she could manage to shift the scale by watching what she ate
Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A multicentre, randomised, double-blind, placebo-controlled study
Lingvay has received research funding, advisory/consulting fees and/or other support from Novo Nordisk, and her other disclosures can be found in the manuscript.
Chakrapani H, Kalathur RC, Maciag AE, Citro ML, Ji X, Keefer LK, et al
US$ 24.91
US$ 29.21
US$ 20.45
US$ 24.33
US$ 29.48
